SILVER SPRING, Md., May 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that the United States Food and Drug Administration ...
SILVER SPRING, Md.--(BUSINESS WIRE)-- United Therapeutics Corporation and Lung Rx, LLC announced today the launch of a nationwide support program for patients who are currently prescribed a United ...
Gilead Sciences, Inc. GILD announced that the FDA has approved Letairis in combination with Eli Lilly and Company’s LLY Adcirca (tadalafil) for reducing the risk of disease progression and ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
In a recent decision, the Court of Appeals for the Federal Circuit (CAFC) affirmed decisions in two inter-partes review (IPR) proceedings that patents owned by ICOS Corporation directed to tadalafil ...
RTP, North Carolina, 22 March 2010. Synthon Pharmaceuticals Inc. ("Synthon") is confirming today that it has been sued by Eli Lilly and Company ("Lilly") and Icos Corporation ("Icos") in connection ...
Gilead Sciences, Inc.GILD announced that the FDA has approved Letairis in combination with Eli Lilly and Company's LLY Adcirca (tadalafil) for reducing the risk of disease progression and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback